Survivorship | Children with Cancer UK

Filter by Cancer Type

Immunotherapy for relapsed paediatric acute lymphoblastic leukaemia

Immunotherapy for relapsed paediatric acute lymphoblastic leukaemia

Professor Persis Amrolia, UCL Institute of Child Health, London

Reducing toxicity in treatment for children with high-risk neuroblastoma

Combinatorial targeting of Anaplastic Lymphoma Kinase (ALK) for neuroblastoma immunotherapy

Professor John Anderson, Institute of Child Health, University College London

Building on previous successes to improve treatment for acute lymphoblastic leukaemia

UK Acute Lymphoblastic Leukaemia Trial: UKALL 2011

Professor Pamela Kearns, University of Birmingham

Study of the side-effects of the anti-leukaemia drug Asparaginase

Pathophysiology of asparaginase associated pancreatitis

Dr Oleg Gerasimenko, Cardiff University

Supporting Acute Myeloid Leukaemia research

Senior lecturer in translational paediatric haemopoiesis

Professor Tessa Holyoake, University of Glasgow

Reducing setbacks by tailoring individual therapy in childhood acute lymphoblastic leukaemia

Optimisation of the use of L-Asparaginase and Dexamethasone in Childhood Acute Lymphoblastic Leukaemia

Professor Vaskar Saha, University of Manchester

1 2 3 4 5 6